Medulloblastoma Clinical Trials

Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers
Last Updated: 2022-05-17
Originally Posted: 2017-05-31

Rare CNS Tumors Outcomes &Risk
Last Updated: 2022-05-17
Originally Posted: 2017-08-15

Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery
Last Updated: 2022-05-16
Originally Posted: 2019-04-01

Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)
Last Updated: 2022-05-14
Originally Posted: 2019-12-11

Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
Last Updated: 2022-05-14
Originally Posted: 2020-02-25

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
Last Updated: 2022-05-14
Originally Posted: 2017-07-10

Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Last Updated: 2022-05-14
Originally Posted: 2017-07-10

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)
Last Updated: 2022-05-14
Originally Posted: 2018-05-15

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Last Updated: 2022-05-13
Originally Posted: 2017-07-10

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial
Last Updated: 2022-05-13
Originally Posted: 2020-03-24

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
Last Updated: 2022-05-13
Originally Posted: 2013-06-10

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Last Updated: 2022-05-13
Originally Posted: 2017-05-15

Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study
Last Updated: 2022-05-12
Originally Posted: 2021-11-05

Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
Last Updated: 2022-05-06
Originally Posted: 2016-03-25

Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Last Updated: 2022-05-02
Originally Posted: 2019-11-26

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
Last Updated: 2022-05-01
Originally Posted: 2016-01-04

Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma
Last Updated: 2022-04-26
Originally Posted: 2021-09-15

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Last Updated: 2022-04-20
Originally Posted: 2021-01-04

Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors
Last Updated: 2022-04-19
Originally Posted: 2012-07-30

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
Last Updated: 2022-04-19
Originally Posted: 2015-02-09

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Last Updated: 2022-04-11
Originally Posted: 2012-01-04

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT
Last Updated: 2022-04-07
Originally Posted: 2011-05-17

131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
Last Updated: 2022-04-07
Originally Posted: 2021-02-03

Study of Stored Tumor Samples in Young Patients With Brain Tumors
Last Updated: 2022-04-05
Originally Posted: 2009-05-09

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
Last Updated: 2022-04-01
Originally Posted: 2018-02-09

Fimepinostat in Treating Brain Tumors in Children and Young Adults
Last Updated: 2022-03-31
Originally Posted: 2019-03-26

Volitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors
Last Updated: 2022-03-25
Originally Posted: 2018-07-24

Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT
Last Updated: 2022-03-24
Originally Posted: 2016-11-02

177Lu-DTPA-Omburtamab Radioimmunotherapy for Recurrent or Refractory Medulloblastoma
Last Updated: 2022-03-23
Originally Posted: 2019-11-11

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Last Updated: 2022-03-20
Originally Posted: 2021-10-22

Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
Last Updated: 2022-03-11
Originally Posted: 2019-08-02

Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma
Last Updated: 2022-03-09
Originally Posted: 2020-09-16

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Last Updated: 2022-03-05
Originally Posted: 2017-07-06

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Last Updated: 2022-03-01
Originally Posted: 2020-09-01

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Last Updated: 2022-02-25
Originally Posted: 2021-11-04

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
Last Updated: 2022-02-24
Originally Posted: 2017-07-25

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors
Last Updated: 2022-02-16
Originally Posted: 2016-04-27

Apatinib Combined With Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children
Last Updated: 2022-02-10
Originally Posted: 2020-08-04

HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
Last Updated: 2022-02-10
Originally Posted: 2018-03-21

EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
Last Updated: 2022-02-09
Originally Posted: 2018-08-15

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Last Updated: 2022-02-07
Originally Posted: 2019-04-09

A Study of Abemaciclib (LY2835219) in Combination With Temozolomide and Irinotecan and Abemaciclib in Combination With Temozolomide in Children and Young Adult Participants With Solid Tumors
Last Updated: 2022-02-03
Originally Posted: 2020-01-22

DOTATOC PET/CT for Imaging NET Patients
Last Updated: 2022-02-02
Originally Posted: 2018-06-08

PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma
Last Updated: 2022-01-08
Originally Posted: 2017-09-27

A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer
Last Updated: 2022-01-04
Originally Posted: 2021-01-26

Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer
Last Updated: 2021-12-19
Originally Posted: 2019-04-30

An International Prospective Trial On High-risk Medulloblastoma In Patients Older Than 3 Years
Last Updated: 2021-12-10
Originally Posted: 2021-12-10

Temokids Study (orp-tmz-i- B): A Population Pharmacokinetic, Acceptability And Safety Study For Kimozo, A Paediatric Oral Suspension Of Temozolomide
Last Updated: 2021-12-07
Originally Posted: 2021-12-07

Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma
Last Updated: 2021-11-30
Originally Posted: 2018-03-20

NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
Last Updated: 2021-11-20
Originally Posted: 2021-11-05

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
Last Updated: 2021-11-19
Originally Posted: 2018-10-09

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
Last Updated: 2021-11-18
Originally Posted: 2021-02-04

Personalized Risk-adapted Therapy In Post-pubertal Patients With Newly Diagnosed Medulloblastoma (persomed-i)
Last Updated: 2021-11-10
Originally Posted: 2021-11-10

Efficacy of Dual Task Training on Children With Ataxia After Medulloblastoma Resection
Last Updated: 2021-11-06
Originally Posted: 2021-10-02

An International Prospective Trial On High-risk Medulloblastoma In Patients Older Than 3 Years
Last Updated: 2021-11-03
Originally Posted: 2021-11-03

Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors
Last Updated: 2021-10-28
Originally Posted: 2015-10-02

Methotrexate and Etoposide Infusions Into the Fourth Ventricle in Children With Recurrent Posterior Fossa Brain Tumors
Last Updated: 2021-10-27
Originally Posted: 2016-09-07

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
Last Updated: 2021-10-26
Originally Posted: 2020-03-30

Focal Radiotherapy Plus Low Dose Craniospinal Irradiation Followed by Adjuvant Chemotherapy in WNT Medulloblastoma.
Last Updated: 2021-10-05
Originally Posted: 2020-07-14

68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
Last Updated: 2021-09-30
Originally Posted: 2019-09-04

Phase I Study of APX005M in Pediatric CNS Tumors
Last Updated: 2021-09-21
Originally Posted: 2017-12-15

Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
Last Updated: 2021-09-17
Originally Posted: 2015-12-27

An International Prospective Trial On High-risk Medulloblastoma In Patients Older Than 3 Years
Last Updated: 2021-09-15
Originally Posted: 2021-09-15

Randomized Study To Protect From Radiation Iatrogenic Hypothyroidism Patients With Medulloblastoma (any Age, Stage And Any Biological Risk) And Pediatric Patients With Hodgkin Lymphoma And Non-hodgkin Lymphoma Needing Radiation Therapy On Thyroid Site
Last Updated: 2021-08-30
Originally Posted: 2021-08-30

An International Prospective Trial On High-risk Medulloblastoma In Patients Older Than 3 Years
Last Updated: 2021-08-30
Originally Posted: 2021-08-30

Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy
Last Updated: 2021-08-21
Originally Posted: 2021-02-08

Infusion of Panobinostat (MTX110) Into the Fourth Ventricle in Children and Adults With Recurrent Medulloblastoma
Last Updated: 2021-08-03
Originally Posted: 2020-03-17

Phase 1/2 Study Of Bempegaldesleukin In Combination With Nivolumab In Children, Adolescents, And Young Adults With Recurrent Or Refractory Malignancies (pivot Io 020)
Last Updated: 2021-08-02
Originally Posted: 2021-08-02

AflacST1901: Peds WP1066
Last Updated: 2021-07-13
Originally Posted: 2020-04-02

Methionine PET/CT Studies In Patients With Cancer
Last Updated: 2021-07-01
Originally Posted: 2009-02-09

A Phase I/ii Dose-escalation And Expansion Cohort Trial Of Intracerebroventricular Radioimmunotherapy Using 177lu-dtpa-omburtamab In Pediatric And Adolescent Patients With Recurrent Or Refractory Medulloblastoma
Last Updated: 2021-06-28
Originally Posted: 2021-06-28

An International Prospective Trial On High-risk Medulloblastoma In Patients Older Than 3 Years
Last Updated: 2021-06-21
Originally Posted: 2021-06-21

A Phase 1b Dose Escalation Study Of Abemaciclib In Combination With Temozolomide And Irinotecan (part A) And Abemaciclib In Combination With Temozolomide (part B) In Pediatric And Young Adult Patients With Relapsed/refractory Solid Tumors -p/376/2019
Last Updated: 2021-05-24
Originally Posted: 2021-05-24

Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors
Last Updated: 2021-05-07
Originally Posted: 2019-07-11

Phase 1/2 Study Of Bempegaldesleukin In Combination With Nivolumab In Children, Adolescents, And Young Adults With Recurrent Or Refractory Malignancies (pivot Io 020)
Last Updated: 2021-05-05
Originally Posted: 2021-05-05

Dual Task Training On Children With Ataxia After Medulloblastoma Resection
Last Updated: 2021-04-22
Originally Posted: 2021-03-21

Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Last Updated: 2021-04-02
Originally Posted: 2018-10-05

Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
Last Updated: 2021-03-23
Originally Posted: 2017-02-02

Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer
Last Updated: 2021-02-18
Originally Posted: 2020-08-18

Phase 1/2 Study Of Bempegaldesleukin In Combination With Nivolumab In Children, Adolescents, And Young Adults With Recurrent Or Refractory Malignancies (pivot Io 020)
Last Updated: 2021-02-09
Originally Posted: 2021-02-09

Temokids Study (orp-tmz-i- B): A Population Pharmacokinetic, Acceptability And Safety Study For Kimozo, A Paediatric Oral Suspension Of Temozolomide
Last Updated: 2021-02-01
Originally Posted: 2021-02-01

Phase 1/2 Study Of Bempegaldesleukin In Combination With Nivolumab In Children, Adolescents, And Young Adults With Recurrent Or Refractory Malignancies (pivot Io 020)
Last Updated: 2021-02-01
Originally Posted: 2021-02-01

An Interventional, Open-label, Phase Ii Study, To Evaluate Safety And Efficacy Of Standard And High-dose Chemotherapy Associated With Craniospinal Irradiation In Patients With Metastatic Medulloblastoma And Other Embryonal Tumours
Last Updated: 2020-12-09
Originally Posted: 2020-12-09

Child's Study of the Impact of PF Lesion on Motor Skills, Language, Cognitive Functioning and Social Cognition
Last Updated: 2020-11-17
Originally Posted: 2019-11-08

Temokids Study (orp-tmz-i- B): A Population Pharmacokinetic, Acceptability And Safety Study For Kimozo, A Paediatric Oral Suspension Of Temozolomide
Last Updated: 2020-10-05
Originally Posted: 2020-10-05

Physical Activity on Postural Stability and Coordination in Children With Posterior Fossa Tumor
Last Updated: 2020-09-16
Originally Posted: 2020-08-24

Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors
Last Updated: 2020-09-15
Originally Posted: 2009-09-23

Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
Last Updated: 2020-08-27
Originally Posted: 2017-07-10

A Phase 1b Dose Escalation Study Of Abemaciclib In Combination With Temozolomide And Irinotecan (part A) And Abemaciclib In Combination With Temozolomide (part B) In Pediatric And Young Adult Patients With Relapsed/refractory Solid Tumors
Last Updated: 2020-08-12
Originally Posted: 2020-08-12

A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
Last Updated: 2020-07-20
Originally Posted: 2018-11-05

Phase I/ii Open Label, Dose Escalation Trial To Determine The Mtd, Safety, Pk And Efficacy Of Afatinib Monotherapy In Children Aged ≥1 Year To <18 Years With Recurrent/refractory Neuroectodermal Tumours, Rhabdomyosarcoma And/or Other Solid Tumours With Known Erbb Pathway Deregulation Regardless Of Tumour Histology
Last Updated: 2020-07-02
Originally Posted: 2015-05-04

Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Last Updated: 2020-05-14
Originally Posted: 2014-03-13

A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma
Last Updated: 2020-04-01
Originally Posted: 2016-04-08

StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord
Last Updated: 2020-02-25
Originally Posted: 2019-06-17

Components of Social Functioning in Survivors of Pediatric Brain Tumors
Last Updated: 2020-01-17
Originally Posted: 2017-11-28

Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)
Last Updated: 2019-06-19
Originally Posted: 2017-09-01

An International Prospective Trial On Medulloblastoma (mb) In Children Older Than 3 To 5 Years With Wnt Biological Profile (pnet 5 Mb – Lr And Pnet 5 Mb – Wnt-hr), Average-risk Biological Profile (pnet 5 Mb -sr), Or Tp53 Mutation And Registry For Mb Occurring In The Context Of Genetic Predisposition
Last Updated: 2019-06-12
Originally Posted: 2019-06-12

Diffuse Brainstem Glioma Tumour Study: developing new treatment strategies for Diffuse Pontine Glioma
Last Updated: 2019-05-02
Originally Posted: 2012-10-31

A Phase Ii Study Of Metronomic And Targeted Anti-angiogenesis Therapy For Children With Recurrent/progressive Medulloblastoma
Last Updated: 2019-04-04
Originally Posted: 2019-04-04

An International Prospective Trial On Medulloblastoma (mb) In Children Older Than 3 To 5 Years With Wnt Biological Profile (pnet 5 Mb – Lr And Pnet 5 Mb – Wnt-hr), Average-risk Biological Profile (pnet 5 Mb -sr), Or Tp53 Mutation And Registry For Mb Occurring In The Context Of Genetic Predisposition
Last Updated: 2019-02-13
Originally Posted: 2019-02-13

A study to evaluate the safety,tolerability and pharmacokinetics of ACT001 in children with advanced brain and solid tumors
Last Updated: 2018-11-28
Originally Posted: 2018-11-05

Study of Tomotherapy HD in Medulloblastoma
Last Updated: 2018-09-16
Originally Posted: 2018-09-16

Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas
Last Updated: 2018-07-03
Originally Posted: 2013-05-16

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
Last Updated: 2018-04-13
Originally Posted: 2004-08-04

A Phase 2 Clinical Study Of Pomalidomide (cc-4047) Monotherapy For Children And Young Adults With Recurrent Or Progressive Primary Brain Tumors.
Last Updated: 2018-01-30
Originally Posted: 2018-01-30

International HIT-MED Registry (I-HIT-MED)
Last Updated: 2017-10-17
Originally Posted: 2015-02-04

A Phase 2 Clinical Study Of Pomalidomide (cc-4047) Monotherapy For Children And Young Adults With Recurrent Or Progressive Primary Brain Tumors.
Last Updated: 2017-09-26
Originally Posted: 2017-09-26

A Phase 2 Clinical Study Of Pomalidomide (cc-4047) Monotherapy For Children And Young Adults With Recurrent Or Progressive Primary Brain Tumors.
Last Updated: 2017-07-27
Originally Posted: 2017-07-27

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma
Last Updated: 2017-05-05
Originally Posted: 2014-02-07

An International Prospective Study On Clinically Standard-risk Medulloblastoma In Children Older Than 3 To 5 Years With Low-risk Biological Profile (pnet 5 Mb - Lr) Or Average-risk Biological Profile (pnet 5 Mb -sr)
Last Updated: 2016-10-21
Originally Posted: 2016-10-21

Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma
Last Updated: 2016-06-08
Originally Posted: 2013-12-30

An International Prospective Study On Clinically Standard-risk Medulloblastoma In Children Older Than 3 To 5 Years With Low-risk Biological Profile (pnet 5 Mb - Lr) Or Average-risk Biological Profile (pnet 5 Mb -sr)
Last Updated: 2016-03-09
Originally Posted: 2016-03-09

An International Prospective Study On Clinically Standard-risk Medulloblastoma In Children Older Than 3 To 5 Years With Low-risk Biological Profile (pnet 5 Mb - Lr) Or Average-risk Biological Profile (pnet 5 Mb -sr)
Last Updated: 2015-07-31
Originally Posted: 2015-07-31

A Phase Ii Study Of Metronomic And Targeted Anti-angiogenesis Therapy For Children With Recurrent/progressive Medulloblastoma
Last Updated: 2015-06-16
Originally Posted: 2015-06-16

A Phase Ii Study Of Metronomic And Targeted Anti-angiogenesis Therapy For Children With Recurrent/progressive Medulloblastoma
Last Updated: 2015-06-11
Originally Posted: 2015-06-11

An International Prospective Trial On Medulloblastoma (mb) In Children Older Than 3 To 5 Years With Wnt Biological Profile (pnet 5 Mb – Lr And Pnet 5 Mb – Wnt-hr), Average-risk Biological Profile (pnet 5 Mb -sr), Or Tp53 Mutation And Registry For Mb Occurring In The Context Of Genetic Predisposition
Last Updated: 2015-05-22
Originally Posted: 2015-05-22

An International Prospective Study On Clinically Standard-risk Medulloblastoma In Children Older Than 3 To 5 Years With Low-risk Biological Profile (pnet 5 Mb - Lr) Or Average-risk Biological Profile (pnet 5 Mb -sr)
Last Updated: 2015-03-31
Originally Posted: 2015-03-31

Phase I/ii Open Label, Dose Escalation Trial To Determine The Mtd, Safety, Pk And Efficacy Of Afatinib Monotherapy In Children Aged ≥ 1 Year To <18 Years With Recurrent/refractory Neuroectodermal Tumours, Rhabdomyosarcoma And/or Other Solid Tumours With Known Erbb Pathway Deregulation Regardless Of Tumour Histology
Last Updated: 2015-02-11
Originally Posted: 2015-02-11

An International Prospective Study On Clinically Standard-risk Medulloblastoma In Children Older Than 3 To 5 Years With Low-risk Biological Profile (pnet 5 Mb - Lr) Or Average-risk Biological Profile (pnet 5 Mb -sr)
Last Updated: 2015-01-07
Originally Posted: 2015-01-07

A Phase Ii Study Of Metronomic And Targeted Anti-angiogenesis Therapy For Children With Recurrent/progressive Medulloblastoma
Last Updated: 2014-03-26
Originally Posted: 2014-03-26

An International Prospective Study On Clinically Standard-risk Medulloblastoma In Children Older Than 3 To 5 Years With Low-risk Biological Profile (pnet 5 Mb - Lr) Or Average-risk Biological Profile (pnet 5 Mb -sr)
Last Updated: 2014-01-09
Originally Posted: 2014-01-09

An International Prospective Study On Clinically Standard-risk Medulloblastoma In Children Older Than 3 To 5 Years With Low-risk Biological Profile (pnet 5 Mb - Lr) Or Average-risk Biological Profile (pnet 5 Mb -sr)
Last Updated: 2013-12-10
Originally Posted: 2013-12-10

Phase I / Ii Study Of Sequential High-dose Chemotherapy With Stem Cell Support In Children Younger Than 5 Years Of Age With High-risk Medulloblastoma
Last Updated: 2013-05-22
Originally Posted: 2013-05-22

A Phase Ii Study Of Metronomic And Targeted Anti-angiogenesis Therapy For Children With Recurrent/progressive Medulloblastoma
Last Updated: 2012-04-20
Originally Posted: 2012-04-20

An International Prospective Trial On Medulloblastoma (mb) In Children Older Than 3 To 5 Years With Wnt Biological Profile (pnet 5 Mb – Lr And Pnet 5 Mb – Wnt-hr), Average-risk Biological Profile (pnet 5 Mb -sr), Or Tp53 Mutation And Registry For Mb Occurring In The Context Of Genetic Predisposition
Last Updated: 2011-11-24
Originally Posted: 2011-11-24

A Phase Ii Study Of Metronomic And Targeted Anti-angiogenesis Therapy For Children With Recurrent/progressive Medulloblastoma
Last Updated: 2011-04-12
Originally Posted: 2011-04-12

Estudio Fase Ii No Aleatorizado De Tratamiento Con Temozolamida Combinada Con Topotecan Para Neuroblastoma Y Otros Tumores Sólidos Pediátricos En Situación De Recaída O Progresión. "phase 2 Single-arm Studies Of Temozolamide Incombination With Topotecan In Refractory And Relapsed Neuroblastoma And Other Paediatric Solid Tumours"
Last Updated: 2010-03-03
Originally Posted: 2010-03-03

Acns0331 A Study Evaluating Limited Target Volume Boost Irradiation And Reduced Dose Craniospinal Radiotherapy (18.00 Gy) And Chemotherapy In Children With Newly Diagnosed Standard Risk Medulloblastoma: A Phase Iii Double Randomized Trial. An Intergroup Study For Participation By Cog And The Dutch Childhood Oncology Group – Skion (stichting Kinderoncologie Nederland)
Last Updated: 2009-08-18
Originally Posted: 2009-08-18

Phase 2 Single-arm Studies Of Temozolomide In Combination With Topotecan In Refractory Or Relapsing Neuroblastoma And Other Pediatric Solid Tumours.
Last Updated: 2009-07-08
Originally Posted: 2009-07-08

Phase 2 Single-arm Studies Of Temozolomide In Combination With Topotecan In Refractory Or Relapsing Neuroblastoma And Other Pediatric Solid Tumours.
Last Updated: 2008-05-16
Originally Posted: 2008-05-16

Phase 2 Single-arm Studies Of Gemcitabine In Combination With Oxaliplatin In Refractory And Relapsed Pediatric Solid Tumors. (etude De Phase Ii De L’association Gemcitabine - Oxaliplatine « Gemox » Chez Les Patients Porteurs D’une Tumeur Solide Maligne Réfractaire Ou En Rechute).
Last Updated: 2007-05-10
Originally Posted: 2007-05-10